Overview

A Study in Evaluating Bioequivalence Between Test and Reference Formulations of Vadadustat Tablets in Healthy Adults

Status:
Completed
Trial end date:
2018-05-23
Target enrollment:
Participant gender:
Summary
This study is to assess the bioequivalence of a test formulation of vadadustat (A) compared to a reference formulation of vadadustat (B)
Phase:
Phase 1
Details
Lead Sponsor:
Akebia Therapeutics
Treatments:
Glycine